Nanoparticle compositions and methods for immunotherapy
US11510981B2 · kind B2 · utility
0Cited by
7References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 18, 2020 |
| Grant date | Nov 29, 2022 |
| Priority date | — |
| Expiry date | Jan 23, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compositions and methods for immunotherapy, which include shelf-stable pharmaceutical compositions for inducing antigen-specific T cells. Such compositions are employed as components of an artificial antigen presenting cell (aAPC), to provide a patient with complexes for presentation of an antigen (e.g., a tumor antigen) and/or a T cell co-stimulatory molecule.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.